IDIBELL on the media
IDIBELL researchers participate in a study that describes a new mechanism of resistance to hepatocellular carcinoma treatment
Identification of the miR-518d-5p molecule in blood is associated with increased resistance to sorafenib treatment and reduced overall survival in patients with hepatocellular carcinoma
Science and performing arts against stereotypes
A study by IDIBELL and UB shows that participation in a workshop combining scientific training and theatre performance reduces implicit biases against physical illnesses
Exercise prevents neuronal damage caused by lung cancer treatment
A study of IDIBELL, ICO, and Bellvitge University Hospital shows that exercise not only prevents the loss of neuronal tissue caused by chemotherapy and radiotherapy. Also, patients who follow sports guidelines increase the volume of gray matter in the brain regions involved in memory and learning functions, such as the hippocampus.
The definition of the metabolic characteristics of breast cancer opens the door to new therapeutic strategies
An international study, with the participation of IDIBELL and ICO, determines that the metabolism of breast tumor cells is defined by their origin.
A new study about the reprogramming of lipid metabolism to combat cellular hepatocarcinoma
A work coordinated by Isabel Fabregat – group leader of TGF-β and Cancer group at IDIBELL and CIBEREHD – University of Barcelona – studies the reprogramming of lipid metabolism and provides new perspectives for the possible use of fatty acids and mitochondrial oxidative metabolism in new pharmacological approaches to decrease the metastasis of hepatocellular carcinoma.
A mouse model to predict the response to the treatment of a myeloma patient
Researchers from IDIBELL and ICO have used an orthotopic mouse model to expand the myeloma patient’s tumor tissue to study his molecular characteristics and response to different treatments.
Tobacco Control Research Groups awarded by the WHO
The Tobacco Control Research Group has received one of the World No Tobacco Day 2021 Awards from the World Health Organization for their work in the field of tobacco control.
Starts the campaign “Let’s push tobacco away”
This campaign, launched by the Catalan Network of Smoke-Free Hospitals, wants to move away tobacco from the hospital environment.
Fernando Fernández Aranda, the new Scientific Director of IDIBELL
Fernando Fernández-Aranda takes over from Josep Manuel Menchón as Scientific Director. This nomination will allow continuing the IDIBELL’s promotion as a reference center in biomedical research.
IDIBELL researchers identify a brain region that predicts the evolution of apathy in Huntington’s patients
The atrophy of a specific region of the cerebral cortex is related to the appearance of apathy in Huntington’s patients, a neurodegenerative disease that affects motor and cognitive function. This is the conclusion of a study of the Bellvitge Biomedical Research Institute (IDIBELL) published in the Movement Disorders journal.